Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2018 (2018), Article ID 8256193, 6 pages
https://doi.org/10.1155/2018/8256193
Research Article

Predictive Role of Serum Cytokine Profiles in Acute Kidney Injury after Living Donor Liver Transplantation

Department of Anesthesiology and Pain Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Correspondence should be addressed to Sang Hyun Hong; moc.liamg@2727gnohhs

Received 17 January 2018; Accepted 7 March 2018; Published 1 April 2018

Academic Editor: Jose Crispin

Copyright © 2018 Min Suk Chae et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. A. Hilmi, D. Damian, A. Al-Khafaji et al., “Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: a propensity score–matched analysis,” Liver Transplantation, vol. 21, no. 9, pp. 1179–1185, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Chae, N. Lee, D. H. Park et al., “Influence of oxygen content immediately after graft reperfusion on occurrence of postoperative acute kidney injury in living donor liver transplantation,” Medicine, vol. 96, no. 31, article e7626, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. H. K. Atalan, B. Gucyetmez, S. Aslan, S. Yazar, and K. Y. Polat, “Postoperative acute kidney injury in living donor liver transplantation recipients,” The International Journal of Artificial Organs, vol. 41, no. 1, pp. 37–42, 2018. View at Publisher · View at Google Scholar
  4. J. M. Zhang and J. An, “Cytokines, inflammation, and pain,” International Anesthesiology Clinics, vol. 45, no. 2, pp. 27–37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Opal and V. A. DePalo, “Anti-inflammatory cytokines,” Chest, vol. 117, no. 4, pp. 1162–1172, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Tilg, A. Kaser, and A. R. Moschen, “How to modulate inflammatory cytokines in liver diseases,” Liver International, vol. 26, no. 9, pp. 1029–1039, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Y. Chen, L. C. Li, and J. L. Yang, “Emerging roles of IL-33/ST2 Axis in renal diseases,” International Journal of Molecular Sciences, vol. 18, no. 12, p. 783, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Su, C. T. Lei, and C. Zhang, “Interleukin-6 signaling pathway and its role in kidney disease: an update,” Frontiers in Immunology, vol. 8, p. 405, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Cortvrindt, R. Speeckaert, A. Moerman, J. R. Delanghe, and M. M. Speeckaert, “The role of interleukin-17A in the pathogenesis of kidney diseases,” Pathology, vol. 49, no. 3, pp. 247–258, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. M. S. Chae, C. S. Park, S. A. Oh, and S. H. Hong, “Predictive role of intraoperative plasma fibrinogen for postoperative portal venous flow in living donor liver transplantation,” Annals of Transplantation, vol. 22, pp. 83–95, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. H. J. Choi, D. G. Kim, G. H. Na et al., “The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation,” Liver Transplantation, vol. 23, no. 8, pp. 1023–1031, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. “KDIGO: Section 2: AKI Definition,” Kidney International Supplements, vol. 2, no. 1, pp. 19–36, 2012. View at Publisher · View at Google Scholar
  13. I. Hilmi, C. N. Horton, R. M. Planinsic et al., “The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation,” Liver Transplantation, vol. 14, no. 4, pp. 504–508, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. A. S. Levey, J. P. Bosch, J. B. Lewis et al., “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Publisher · View at Google Scholar
  15. T. Tanaka, M. Narazaki, and T. Kishimoto, “IL-6 in inflammation, immunity, and disease,” Cold Spring Harbor Perspectives in Biology, vol. 6, no. 10, article a016295, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. P. C. Heinrich, J. V. Castell, and T. Andus, “Interleukin-6 and the acute phase response,” Biochemical Journal, vol. 265, no. 3, pp. 621–636, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Camargo Jr, J. F. Madden, W. Gao, R. S. Selvan, and P. Clavien, “Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent,” Hepatology, vol. 26, no. 6, pp. 1513–1520, 1997. View at Publisher · View at Google Scholar
  18. K. L. Streetz, T. Luedde, M. P. Manns, and C. Trautwein, “Interleukin 6 and liver regeneration,” Gut, vol. 47, no. 2, pp. 309–312, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. B. H. Friedman, J. H. Wolf, L. Wang et al., “Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation,” Liver Transplantation, vol. 18, no. 2, pp. 166–176, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Tanaka and T. Kishimoto, “Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases,” International Journal of Biological Sciences, vol. 8, no. 9, pp. 1227–1236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Remmler, C. Schneider, T. Treuner-Kaueroff et al., “Increased level of interleukin 6 associates with increased 90-day and 1-year mortality in patients with end-stage liver disease,” Clinical Gastroenterology and Hepatology, 2017. View at Publisher · View at Google Scholar
  22. Y. M. Feng, L. Thijs, Z. Y. Zhang et al., “Glomerular function in relation to circulating adhesion molecules and inflammation markers in a general population,” Nephrology Dialysis Transplantation, vol. 33, no. 3, pp. 426–435, 2018. View at Publisher · View at Google Scholar
  23. J. H. Greenberg, R. Whitlock, W. R. Zhang et al., “Interleukin-6 and interleukin-10 as acute kidney injury biomarkers in pediatric cardiac surgery,” Pediatric Nephrology, vol. 30, no. 9, pp. 1519–1527, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. W. R. Zhang, A. X. Garg, S. G. Coca et al., “Plasma IL-6 and IL-10 concentrations predict AKI and long-term mortality in adults after cardiac surgery,” Journal of the American Society of Nephrology, vol. 26, no. 12, pp. 3123–3132, 2015. View at Publisher · View at Google Scholar · View at Scopus